[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 16, 1967

Narcotics and Medical Practice: Medical Use of Morphine and Morphine-like Drugs and Management of Persons Dependent on Them

JAMA. 1967;202(3):209-212. doi:10.1001/jama.1967.03130160083016

One of the major points of the report of the President's Ad Hoc Panel1 as presented to the 1962 White House Conference on Narcotics was that the statutory and regulatory measures for the control of narcotic drugs are not intended to interfere with administration of such drugs in legitimate medical practice. Such administration is legally and medically sound and is approved by enforcement agencies.

The Ad Hoc Panel Report contains a sharp reminder that expressions of prevailing medical opinion have a profound impact not only on medical practice but on regulations,2 laws, and courts, and that it is the duty of the medical profession to review its expressed opinions regularly in order to assure their current validity.

Realizing that, in spite of many attempts at definition of addiction, confusion and inappropriateness in the use of the term persist, the WHO Expert Committee on Addiction-Producing Drugs suggested3 substitution of the term